PubMed Health⌕ Search

Biomedical subjects

A Gusev

Publications and source records attributed to A Gusev.

6 recordsLinked to original sources
PubMed1999

A novel interface for on-line coupling of liquid capillary chromatography with matrix-assisted laser desorption/ionization detection

A novel interface has been developed which should allow the direct on-line coupling of liquid capillary chromatography with matrix-assisted laser desorption/ionization (MALDI) mass spectrometry detection. The interface employs continuous analyte/matrix co-crystallization onto a porous frit installed at a capillary end which is used as the target for MALDI. After separation, the analyte effluent is premixed with the MALDI matrix solution and introduced into the interface. The analyte/matrix mixture is co-crystallized onto the frit surface in the vacuum environment of the mass spectrometer. Continuous matrix/analyte crystallization and interface regeneration is accomplished by a combination of solvent flushing and laser ablation. The memory effect is negligible over a dynamic range of ca. 200. Several applications, including analysis of small peptides and combination with gel permeation chromatography (GPC), have indicated that the on-line MALDI interface does not sacrifice chromatographic or mass spectral resolution, and have demonstrated the possibility of a reliable LC-MALDI system. Copyright 1999 John Wiley & Sons, Ltd.

Journal Article↗
PubMed1993

Use of the polymerase chain reaction in differentiating rinderpest field virus and vaccine virus in the same animals.

In 1991, a disease with clinical signs indicative of rinderpest was reported in yaks in the former Soviet Union, near the border with Mongolia. At the peak of the epizootic, mortality among affected yaks was 32-42% in adults and 65% in animals less than one year old. Pathological samples were examined independently at two institutes in Russia. Both institutes confirmed the presence of rinderpest using complement fixation, agar gel diffusion and immunoassays. Since vaccination had been initiated to control an outbreak of a similar disease several months earlier, the later cases were possibly due to the vaccine and field rinderpest may not have been present. However, the disease had occurred in non-vaccinated animals and these were then vaccinated against the disease. Tissue samples obtained from these animals, which were examined at the Pirbright Laboratory using gel diffusion assays and specific nucleic acid probes, were found to be positive for rinderpest antigen and nucleic acid. Ribonucleic acid derived from the post-mortem tissue samples was amplified using the polymerase chain reaction and rinderpest-specific primers. Sequence analysis of the amplified deoxyribonculeic acid from the samples revealed the presence of two distinct virus strains, one identical to the Plowright rinderpest tissue culture vaccine and the other related to field strains of rinderpest virus circulating in Asia and the Middle East.

Animals↗